Sartorius Stedim Biotech S.A. (SRTOY) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Instruments & Supplies industria. La empresa tiene su sede en Aubagne, France. El CEO actual es Rene Faber.
SRTOY tiene fecha de IPO 2022-02-09, 9,961 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $210.8B.
Sartorius Stedim Biotech S.A. is a global supplier of instruments, consumables, and services for the biopharmaceutical industry. The company provides a comprehensive portfolio including cell lines, culture media, bioreactors, filtration and purification systems, and single-use bioprocess equipment, as well as data analytics software for optimizing biopharmaceutical development and production. It serves pharmaceutical manufacturers, research laboratories, and producers in the food and chemical industries with solutions spanning cell cultivation, fermentation, purification, and product storage and transportation. Founded in 1870 and headquartered in Aubagne, France, Sartorius Stedim Biotech operates as a subsidiary of Sartorius AG.
